You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Pancreatic Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 3 of 3

A Randomized Phase II Study of Perioperative mFOLFIRINOX (study drug) versus Gemcitabine/nab-Paclitaxel (study drug) as Therapy for Resectable Pancreatic Adenocarcinoma

The purpose of this study is to compare the effects of mFOLFIRINOX (oxaliplatin, irinotecan, and fluorouracil) and gemcitabine plus nab-paclitaxel. These chemotherapy drugs will be given before and after surgery. This study will allow the researchers to know if it is a good idea to treat pancreatic cancer with chemotherapy drugs before surgery and if so, to see which of the two drug combinations is better.
Chandravathi Loke, MD
Cancer - Pancreatic, Cancer

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

A phase II trial to study rare tumors

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Baystate Franklin Medical Center
164 High Street
Greenfield, MA 01301

Molecular Analysis for Therapy Choice (MATCH)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Page 1 of 1 | Results 1 - 3 of 3